The LYL1 gene was ®rst identi®ed upon the molecular characterization of the t(7;9)(q35;p13) translocation associated with some human T-cell acute leukemias (TALLs). In adult tissues, LYL1 expression is restricted to hematopoietic cells with the notable exclusion of the T cell lineage. LYL1 encodes a basic helix ± loop ± helix (bHLH) protein highly related to TAL-1, whose activation is also associated with a high proportion of human T-ALLs. A yeast two-hybrid system was used to identify proteins that speci®cally interact with LYL1 and might mediate its activities. We found that p105, the precursor of NF-kB1 p50, was the major LYL1-interacting protein in this system. The association between LYL1 and p105 was con®rmed both in vitro and in vivo in mammalian cells. Biochemical studies indicated that the interaction was mediated by the bHLH motif of LYL1 and the ankyrin-like motifs of p105. Ectopic expression of LYL1 in a human T cell line caused a signi®cant decrease in NF-kB-dependent transcription, associated with a reduced level of NFkB1 proteins.
Introduction
The LYL1 gene was initially identi®ed upon the molecular characterization of the sporadic translocation t(7;19)(q35;p13) associated with human T cell acute leukemia (T-ALL) (Mellentin et al., 1989) . As a consequence of this chromosomal rearrangement, LYL1 coding sequences juxtaposed to the T-cell receptor b gene are constitutively transcribed, whereas no LYL1 expression occurs in normal T cells (Mellentin et al., 1989; Visvader et al., 1991) . LYL1 belongs to the basic helix ± loop ± helix (bHLH) family, several members of which have been implicated in the control of important cellular decisions such as dierentiation or proliferation (Murre et al., 1989b) . The bHLH motif (about 60 aminoacids) forms a structure that mediates dimerization through the HLH domains and DNA-binding through the adjacent basic regions of the dimerized proteins. bHLH proteins have been classi®ed into two main groups. Class A proteins, for instance E2A gene products and HEB in mammals, are widely expressed, in contrast to class B proteins that are expressed in a tissue-speci®c manner (Murre et al., 1989a) . Class A proteins form homodimers as well as heterodimers with other bHLH proteins, while class B proteins do not homodimerize in vivo but form heterodimeric complexes with class A proteins. According to this classi®cation, LYL1 is a class B protein.
Remarkably, two other bHLH factors, TAL-1 (also known as SCL) and TAL-2, related to LYL-1 are also ectopically expressed in human T-ALLs as a consequence of speci®c chromosomal rearrangements (Begley et al., 1989; Bernard et al., 1990; Chen et al., 1990; Xia et al., 1991) . TAL-1, LYL1 and TAL-2, because of the close homology in their bHLH motif (about 90% aminoacids are identical) but also, because of their ectopic expression in the same pathology, have been proposed to constitute the subgroup TAL in the large bHLH family (Baer, 1993) . In addition, all three TAL proteins have been found to dimerize with the E2A proteins and bind the same E box element (AACAGATGGT) (Hsu et al., 1991 (Hsu et al., , 1994a Miyamoto et al., 1996; Xia et al., 1994) . These observations suggest that, in leukemic T cells, the dierent TAL/ E2A heterodimers may control the regulation of a common set of as yet unidenti®ed target genes. Ectopic expression of tal-1 occurs in more than 50% of TALLs and is the most frequent gene dysregulation associated with this pathology (Bash et al., 1995; Bernard et al., 1991; Brown et al., 1990) . We have recently shown that in leukemic T cells, tal-1 displays an antiapoptotic activity, constituting a ®rst clue as to the basis of its oncogenic activity . Since then, the oncogenic potential of tal-1 in T cell lineage has been clearly demonstrated in transgenic mouse models (Condorelli et al., 1996; Kelliher et al., 1996) .
In adult tissues, tal-1 and LYL1 display a largely overlapping pattern of expression in hematopoietic lineages although B cells form an exception since they express LYL1 but not tal-1 at high levels (Kallianpur et al., 1994; Pulford et al., 1995; Visvader et al., 1991) . In contrast, tal-2 expression has not been detected in hematopoietic tissues but only in gonads (Xia et al., 1991) . Targeted gene disruption experiments have recently demonstrated that tal-1 is essential for early embryonic development (Robb et al., 1995; Shivdasani et al., 1995) and for the development of all hematopoietic lineages including the T cell lineage (Porcher et al., 1996; Robb et al., 1996) . Despite the overlap in the LYL1 and tal-1 expression pattern, LYL1 activity does not compensate for the absence of tal-1 in early hematopoiesis, indicating that LYL1 occupies a function distinct from that of tal-1 at least early in development. In more mature hematopoiesis, several studies have demonstrated that tal-1 acts as a positive regulator of normal erythroid dierentiation (Aplan et al., 1992; Green et al., 1991a,b; Mouthon et al., 1993) . TAL-1 protein activity is mediated by speci®c interactions in erythroid cells with the Limonly protein LMO2 which is co-expressed with TAL-1 throughout hematopoiesis and in some leukemic T cells (Ono et al., 1997; Valge-Archer et al., 1994; Wadman et al., 1997) . These observations indicate that, as for other transcription factors, TAL-1 function depends upon interactions with several other proteins. In order to further investigate the biological activity of LYL1, it is important to identify proteins with which it speci®cally interacts, especially since they may mediate LYL1 biological activity. We report here, that NF-kB1 p105 is the major LYL1-interacting protein in the twohybrid system. This interaction involves the bHLH motif of LYL1 and the C-terminus of p105 including the last three ankyrin-like repeats. Moreover, the ectopic expression of LYL1 in T cells signi®cantly aects NF-kB-dependent transcriptional activation suggesting that this interaction may have a physiological signi®cance.
Results

NF-kB1 p105 interacts speci®cally with LYL1
To identify complementary cDNAs encoding proteins that modulate the activity of the LYL1 protein, we used the yeast two-hybrid system (Fields and Song, 1989) . A bait consisting of the amino acids 101 ± 266 of LYL1 including the bHLH domain fused to the LexA DNA binding domain (vector pBTM) was used to screen a cDNA library prepared from the Jurkat T cell line, fused in frame with the Gal4 transactivation domain (vector pGAD, see Materials and methods). From approximately 15 million transformants, 220 positive clones, as determined by activation of his and lacZ reporter genes, were obtained. Partial sequence analysis allowed identi®cation or classi®cation of the clones.
Among the ®rst 50 clones, 37 (74%) contained regions derived from the NF-kB1 cDNA. NF-kB1 belongs to the large NF-kB/Rel family and encodes p105 and p50 proteins (Baeuerle and Baltimore, 1996) . The p50 subunit contains only the amino-terminus of p105 and consists largely of a Rel homology domain (RHD). The carboxy terminus of p105 is characterized by the presence of seven ankyrin-like repeats. This domain mediates inhibition of DNA binding of both p105 and p50 proteins in vitro and restricts p105 to the cytoplasm by masking the nuclear localization signal. The longest NF-kB1 cDNA fragment isolated in our screen encoded residues 200 ± 970 which includes most of the Rel homology domain. The shortest p105 cDNA fragment began at residue 720, corresponding to the fourth ankyrin-like repeat (see Figure 1) , indicating that the LYL1-interacting domain was located within the carboxyterminal region of p105.
Other inhibitors which prevent the nuclear translocation of NF-kB factors, such as IkBa also contain six or seven ankyrin repeats highly related to those of p105. We therefore investigated whether LYL1 interacts with IkBa in a two-hybrid assay in yeast. Cotransformation of yeast cells with pBTM-LYL1 and pGAD-IkBa failed to induce b-galatosidase expression, demonstrating that these two proteins do not interact in yeast ( Figure 1B) .
The HLH domains of LYL1 and TAL-1 are 90% identical at the amino-acid level, de®ning a subgroup of the bHLH family. Therefore, we tested the potential for p105 to interact with TAL-1 in the two-hybrid system. Interestingly, the cDNA clone L12 (see Figure   A 
B
Figure 1 (A) Identi®cation of NF-kB1 p105 as a speci®c interacting partner of LYL1. Schematic representation of p105 protein (969 amino acids); p105 NH2 terminus contains the p50. NRD: NF-kB/Rel/Dorsal domain; D: Dimerization domain; NLS: nuclear localization signal; GGG: glycine-rich region. L2, L12, L5 represent three independent clones encoding portions of p105 which have been isolated in our two-hybrid screen. Note that the smallest LYL1-interacting p105 truncated polypeptide (as encoded by L2) begins at the fourth ankyrine-like repeat of p105. (B) LYL1 speci®cally interacts with NF-kB1 p105 in yeast. Portion of LYL1 and TAL-1 including the bHLH domain, LYL1 full length and Lamin proteins were fused to the DNA binding domain (DBD) of LexA in the yeast expression plasmid pBTM116. LMO-2, IkBa and Raf proteins were fused to the activation domain (AD) of Gal4 in the second expression vector pGAD1318. The DBD fusion proteins were tested with the DA fusion constructs and the clone L12 of p105 isolated from the bank and shown in (A). Ras/Raf interaction was used as a positive control of the experiment. Lamin was used to check the speci®city of the LYL1/p105 interactions. LMO-2 and E47 were used as positive controls for interacting with LYL1 bHLH and Tall bHLH respectively (Hsu et al., 1994b; Wadman et al., 1994) . The full length LYL1 was found to interact with the p105-L12 clone. All TAL-1 bHLH interactions were negative as illustrated by the negative control TAL-1/Raf 1) isolated from the two-hybrid screen, encoding residues 426 ± 969 of p105 fused to GAL4-TA failed to interact with the bHLH domain of TAL-1 fused to the LexA DBD. This indicates that, at least in yeast, the interaction of p105 is speci®c to LYL1 among the bHLH TAL family.
Speci®c in vitro interaction of LYL1 and p105
To substantiate the results obtained in the yeast twohybrid system, we carried out in vitro protein binding assays. Constructs of the bHLH domains of LYL1, TAL-1, TAL-2, E12 and MYOD proteins fused to glutathione-S-transferase (GST) were generated and expressed as recombinant fusion proteins in E. coli (see Materials and methods). Puri®ed GST or GST-bHLH proteins bound to glutathione-Sepharose beads were incubated with 35 S-labeled p105, p50 and IkBa produced by in vitro translation in rabbit reticulocyte lysates. After incubation, beads were extensively washed and the bound proteins were analysed by SDS ± PAGE followed by autoradiography (Figure 2 , top). GST-LYL1bHLH, but neither GST nor other GST-bHLH proteins allowed the ecient retention of p105, thus con®rming the results of the two-hybrid assays in yeast. The interaction of LYL1 and p105 was dependent upon the HLH motif of LYL1, since a GST-fusion LYL1 protein lacking this region did not retain p105. In contrast to the results obtained in the yeast system (Figure 1b) , IkBa was eciently retained by all three GST-TAL bHLH proteins.
p50, which corresponds to the amino-terminus of p105 did not speci®cally interact with the GST-bHLH LYL1 protein although it interacted eciently with MYOD and weakly with all bHLH tested. This con®rmed that the LYL1-interacting domain of p105 was contained within its carboxyterminal region. To more precisely map the LYL1-interacting domain in p105, we constructed two GST fusion proteins containing either residues corresponding to the ankyrin-like repeats (aa 425-818; p105AR) or residues containing only the extreme carboxy-terminus of p105 (aa 817 ± 969; p105 C-term) and used them in a pulldown assay with in vitro translated LYL1 proteins. As shown in Figure 2 (bottom), only the GST-p105AR was able to retain LYL1. Taken together, these experiments indicate that LYL1 and p105 physically interact in vitro through the bHLH motif of LYL1 and ankyrin-like repeats of p105.
Speci®c and ecient capture of p105 in cell lysates by GST-LYL1 proteins
To con®rm the interaction of p105 and LYL1, we incubated cell lysates from the Jurkat T cell line, which does not express LYL1, and the LYL1-expressing erythroid cell line K562 with the panel of GST fusion proteins described above. After extensive washing, bound proteins were analysed by Western blotting and revealed with an antiserum directed against the carboxyterminus of human p105 ( Figure 3A ). In control lysates from both K562 and Jurkat cells, antip105 recognized a unique band migrating around 100 kDa. This band was retained exclusively by GST-LYL bHLH but not by any other GST-bHLH proteins tested. The use of an antibody speci®c to the aminoterminus of p105 gave the same results (not shown), thus con®rming the identity of the band around 100 kDa as NF-kB1 105. p105 from both cell lysates was also very eciently captured by a GST protein fused to the full length LYL1 protein. p105 appeared to be more eciently captured by GST-LYL1 than by the GST-LYL bHLH protein. This may be due to a decreased accessibility of the HLH motif (residues 164 ± 203) in the context of the truncated GST-LYL bHLH protein which contains only residues 114 to 221 as compared to the large LYL protein which harbors residues 16 to 280. We noticed that both GST-LYL proteins capture p105 less eciently in K562 cell extracts than in those of Jurkat, although we cannot explain this dierence. In contrast, exposure of the blot to an anti-IkBa antibody revealed a doublet at 38 ± 40 kDa in control lysates but no speci®c band was Figure 2 In vitro association of NF-kB1 p105, NF-kB1 p50, IkBa with LYL1 and various bHLH proteins. (Top) Portions of the three TAL proteins including their bHLH motif, a truncated LYL1 protein LYL1 DbHLH, MyoD or E12 protein were fused to GST and expressed in bacteria, puri®ed and coupled to agarose beads. GST was also expressed alone to serve as a negative control. In vitro translated radiolabeled proteins p105, p50 and IkBa were incubated with the indicated GST protein. Proteins retained on GST-fusions were analysed by SDS ± PAGE and autoradiographed. Within the TAL family, p105 was speci®cally retained by GST-LYL1. GST-LYL1 DbHLH did not retain p105, indicating the interaction is mediated by the bHLH motif of LYL1. p50 showed a signi®cant interaction with MyoD, while IkBa exhibited an interaction with the three TAL proteins and to a lesser extent, with MyoD. (Bottom) The domain including ankyrin repeats (aa 425 ± 818, AR) and the C-terminal domain of p105 (aa 817 ± 969, C-term) were fused to GST and puri®ed as previously described. They were incubated with in vitro translated radiolabeled protein LYL1. The results showed that the interaction with LYL1 is mediated by the ankyrin-like motifs. Lanes`untreated lysate': 1 ml of translation mix was loaded prior GST-pull down experiments. The volume of in vitro translated proteins used for each interaction were determined according to the labeling and were 1 ml for p105; 10 ml for p50; 2 ml IkBa; 10 ml of LYL1 LYL1 and NF-kB1 p105 interaction R Ferrier et al retained by any GST-bHLH fusions, including the GST-LYL1 proteins ( Figure 3B ).
The results of these in vitro interactions are consistent with the data obtained in the yeast twohybrid experiments and clearly demonstrate that NFkB1 p105 speci®cally interacts with LYL1 but not with other TAL bHLH proteins. Additionally, LYL1 interacts speci®cally with p105 but not with other members of the NF-kB/Rel family.
Association of LYL1 and p105 proteins in mammalian cells
We extended our analysis to determine whether the interaction between LYL1 and p105 also occurs in mammalian cells. Expression vectors encoding LYL1 and p105 fused to the MYC epitope tag (pCS3-p105) were transfected into Cos 7 cells either separately or together. Whole cell extracts were divided and subjected to either direct immunoblotting analysis for the presence of MYC-p105 and LYL1 proteins or immunoprecipitation with the anti-LYL1 serum followed by immunoblotting with the anti-MYC monoclonal antibody (Mab) 9E10. Myc-p105 was recognized by the Mab 9E10 as a major band around p110 kDa ( Figure 4B -a: lanes 1 ± 3). As shown in Figure 4A , the rabbit polyclonal serum anti-LYL1 detected several LYL1 proteins species in mammalian cells. The pluripotent hematopoietic cell line UT7, used here as a control of endogenous LYL1 expression, displayed large LYL1 proteins migrating as a doublet at the position 46 ± 48 kDa and small species around 14 kDa. The small 14 kDa species were the major LYL1 products detected as well in transiently transfected Cos 7 (Figure 4b -b, lanes 2 ± 5) as in stably transfected Jurkat T cells (see Figure  4a ). Since the antibody was raised against a polypeptide containig the C-terminus including the HLH motif (Miyamoto et al., 1996) , we can speculate that these short species contain the entire HLH. The apparent molecular weight (14 kD) is compatible with this hypothesis. The large forms 46/48 were detected, albeit as a minor fraction, only in those transfection experiments ( Figure 4B -b, lanes 3 and 5) in which LYL1 expression was produced from the cDNA Lyl-LF (see Materials and methods), encompassing the potential CTG translation initiation codon as de- Figure 3 Ecient capture of NF-kB1 p105 in cellular extracts by GST-LYL1 fusion proteins. Lysates prepared from Jurkat or K562 cells were incubated with the indicated GST-fusion proteins coupled to agarose beads. After extensive washing, bound proteins or whole cell lysates were analysed on a Western blot probed with speci®c antibodies directed against either the Cterminus of p105 (A) or IkBa (B). Only GST-LYL1bHLH and GST-LYL1 full length eciently retained p105 from both extracts. IkBa was not retained by any of the GST fusions scribed (Mellentin et al., 1989) . Additional minor bands were also detected at position 24 ± 25 kDa ( Figure 4B -b, lanes 2 ± 5) which are likely to correspond to intermediate forms of LYL1 proteins. As shown in Figure 4b -g, anti-Myc immunoblotting of LYL1 immunoprecipitates revealed the presence of the Myc-p105 in cell extracts derived from cells transfected with one of the LYL1 expression vectors together with the Myc-p105 expression vector (lanes 2 and 3), but not in extracts of Cos 7 cells transfected with the Myc-p105 expression vector alone (lane 1). Pre-immune serum, used as a control for the LYL1 antiserum, failed to co-immunoprecipitate Myc-p105 in similar experiments (data not shown). As expected, no band migrating at 110 kDa was detected in extracts of Cos 7 cells transfected with a LYL1 expression vector alone.
These experiments clearly demonstrated that LYL1 and p105 can also speci®cally associate in mammalian cells.
Ectopic LYL1 expression reduces NF-kB-dependent transcription in Jurkat T cells
We next asked whether LYL1 expression in a T cell context in¯uences NF-kB activity. NF-kB/Rel factors exist in the cytosol of many cell types as an inactive complex of Rel-related factors, bound to one of the inhibitory IkBs. NF-kB can be induced by a variety of signals, including mitogens, cytokines and bacterial liposaccharides. Treatment of cells with an inducer leads to phosphorylation, ubiquitination and degradation of inhibitory molecules such as IkBa or p105, releasing NF-kB factors and allowing their translocation into the nucleus and transactivation of target genes (Finco and Baldwin, 1995; Fujimoto et al., 1995) .
The eect of transient LYL1 expression on NF-kBdependent transcription was assessed in the Jurkat T cell line. Luciferase reporter constructs containing either the minimal chicken conalbumin promoter (cona-Luc) or a promoter with three additional adjacent NF-kB sites from the Ig-K enhancer ((Igk)3-cona-Luc) were co-transfected into Jurkat cells with an expression vector containing cDNAs to be tested under the control of the SRa promoter. A Renilla luciferase control vector (TK-RL) was also introduced to normalize for transfection eciencies. After 40 h, cells were either left unstimulated or stimulated for 6 h with phorbol 12-myristate 13-acetate (PMA) and luciferase activity was assessed.
As expected, in non transfected cells, NF-kBdependent activity was low without inducer, and PMA addition caused a dramatic stimulation of NFkB-dependent transcription reaching the maximum, up to 500-fold higher than that observed with conapromoter alone, after a 6 h treatment with PMA (data not shown). Upon induction with PMA ( Figure 5A ), a signi®cant decrease, around 25%, in the amount of NF-kB-dependent transcription, was repeatedly observed in the presence of LYL1 (Mann and Whitney's test, a50.01). In addition, this inhibitory eect was found to be dependent on the dose of the transfected LYL1 expression vector (see Figure 5B) . Transfection of the LYL1-related TAL1 protein along with the (Igk)3-reporter had no eect on PMA-induced NF-kB activity (see Figure 5A and B). Used as a control, transient expression of IkBa under the same conditions led to a strong inhibition (about 60%) of NFkB-dependent transcription in induced cells ( Figure  5a ).
To provide further evidence for the inhibitory eects of LYL1 on NF-kB activity, we established stable transfectants of Jurkat T cells using an expression 6 Jurkat cells were transfected with 1 mg of conaluc or (Igk)3 luc reporter together with either the empty expression vector (SRa) and/or increasing amount of the expression vector encoding LYL1. A total amount of 1 mg of SRa vector (empty plus LYL1-expressing) was kept constant with the indicated ratios. 0.2 mg of TK-RL was also added as an indicator of transfection eciency. Forty-eight hours post-transfection, cells were activated for 6 h with PMA and luciferase activity was analysed. For each ratio, Igk-luc activity was normalized with its own conaluc activity measured prior to activation. The data presented are the average of ®ve independent repetitions, the error bars represent standard deviation of the mean. The data were submitted to a Mann and Whitney's statistical test and showed a signi®cant statistical dierence (a50.01) between the empty vector and the LYL1 expression vector LYL1 and NF-kB1 p105 interaction R Ferrier et al vector containing the LYL1 coding sequences under the control of the strong CMV immediate early promoter. Several clones which transcribed LYL1 at high levels were isolated ( Figure 6 ) and further analysed. A control line was also established that contained the empty vector and the neomycine resistance selectable marker. We then investigated NF-kB activity in dierent established cell lines by transient transactivation assays using the same kB reporter as in experiments described above. NF-kBdependent transcriptional activity was dramatically lower (decreased by 60%) in LYL1-expressing cells as compared to the control cell line (Mann and Whitney's test, a50.01), in both uninduced cultures ( Figure 7A ) and after PMA stimulation ( Figure 7B ). Similar results were obtained with isolated clones (cl 60 and cl 62) as well as with the pooled population, indicating that the observed eect was indeed due to the ectopic expression of LYL1 and not a result of clonal variation. We did not observe any alteration in the kinetics of NF-kB activation by PMA in LYL1-transfected cells ( Figure 7C ), thus excluding the possibility that the observed decrease was due to a delay in the activation processes. Furthermore, a similar inhibition of NF-kB-dependent transcription was observed in LYL1-expressing cells using other inducers of NF-kB, such as tumor necrosis factor alpha (TNF-a; see Figure 7D ).
Thus, constitutive expression of LYL1 led to a signi®cant reduction of NF-kB activity in Jurkat T cells.
High ectopic expression of LYL1 proteins correlates with reduced p105 protein level in Jurkat T cells
We then investigated whether the decrease of NF-kB transcriptional activity in T cells constitutively expressing LYL1, might be associated with changes of NFkB1 proteins levels. We performed Western blot analysis of cellular extracts derived from uninduced cells using either an antibody directed to the NH2 terminus of p105, which recognizes both p105 and p50 or the LYL1 antibody. The blots were also probed with an anti GAPDH antibody to provide a loading control. The immunoblots (Figure 8 ) revealed that, compared to the empty cell line, the amount of p105 was signi®cantly reduced in Jurkat subclones (LYL 60 and LYL 62) which express high levels of LYL1 proteins. In addition, we noticed an increase in the amount of p50 in both LYL 60 and LYL 62. In contrast, we did not observe any signi®cant change of p105 and p50 amounts in those clones (LYL 42 and LYL 57) which express LYL1 products at very low levels. These data indicated that high ectopic expression of LYL1 correlates with reduction of NF-kB1 p105 precursor in Jurkat cells, accompanied by an increase in the amount of p50, thus leading to a signi®cant modi®cation of the ratio p105 to p50 in Jurkat cells. 6 Jurkat cells were transfected with 1 mg of either (Igk)3-luc plasmid or conaluc reporter plasmid (Fire¯y luciferase) together with 0.2 mg of TK-RL reporter plasmid (Renilla luciferase). Forty hours later, Igk-luc transfected cells were activated with PMA (60 ng/ml) for the indicated duration. Transfection eciencies were normalized with Renilla luciferase activity. Fire¯y luciferase activities of (Igk)3 luc transfections were compared to Fire¯y luciferase activity of the cona minimal promoter measured at initial time
Discussion
In normal tissues, LYL1 expression appears to be restricted to hematopoietic cells with the notable exception of mature T cells (Visvader et al., 1991) . However, it is found in some human T cell leukemias, suggesting that it may participate in T cell leukemogenesis, even though its oncogenic potential has thus far not been demonstrated in a mouse transgenic model. The biological activity of LYL1 in normal hematopoiesis as well as in T cell leukemia is still unkwown. Because of the presence of the bHLH motif, LYL1 is likely to act, as other members of the bHLH family, as a transcription factor controlling the expression of target genes. It is clear that proteinprotein interactions can modulate either the activity or the stability of many transcription factors. In this study, we have used the yeast two-hybrid system to isolate cDNAs coding for proteins that interact with LYL1 and have identi®ed NF-kB1 p105 as the major LYL1-interacting protein.
A previously reported yeast two-hybrid screen identi®ed E2A HLH protein as the major partner of LYL1 (Miyamoto et al., 1996) . In our screen, cDNAs encoding E2A proteins represent only 3% of the isolated clones and we found that the two proteins interacted poorly in both the yeast system and in vitro experiments (Ferrier and Mathieu-Mahul unpublished results). The discrepancy between the two studies may be due to the cellular origin of the cDNA libraries used for the screen as B lymphocytes were used in the previous study and our library was derived from the Jurkat T cell here. B cells are known to express 10 ± 100-fold higher levels of E2A products than any other hematopoietic cells, including T lymphocytes (Bain et al., 1994) .
Our experiments demonstrated that the LYL1/p105 association required the HLH domain of LYL1 and the carboxyterminal ankyrin-like repeats of p105. Both of these structural motifs are known to mediate interactions with other protein partners. A proteinprotein interaction mediated by a HLH motif and an ankyrin-like domain have previously been described to aect the dimerization and DNA-binding properties of a bHLH protein (Klein et al., 1993) . The relevance of p105/LYL1 interaction was reinforced by our ®ndings of an ecient capture of p105 by bacterially expressed GST-LYL1 in crude T cell lysates as well as coimmunoprecipitation of both proteins in transfected mammalian cells. However only a small fraction of p105 appeared to be associated with LYL1. One possibility is that p105 and LYL1 interact very transiently, presumably because of their ®nal localizations within the cell. p105 is known to be retained in the cytoplasm of non activated T cells, while LYL1 protein, as most of bHLH proteins, is likely to be essentially nuclear. Yet, ectopically expressed TAL-1 proteins were detected in both cytoplasmic and nuclear fractions of transfected cells (Goldfarb et al., 1992; Mahajan et al., 1996) and were shown to interact with the DRG protein in this compartment (Mahajan et al., 1996) . This might also be the case for overexpressed LYL1 proteins.
Remarkably, the p105/LYL1 interaction was found to be highly speci®c among both the bHLH family and the NF-kB/Rel family. Notably, we did not observe signi®cant interaction between p105 and the two LYL1-related TAL1 and TAL2 proteins which share about 90% of identity in their bHLH motif (Baer, 1993) . Similarly, no cDNA clone derived from the NFkB2 gene were isolated in our screen, although NF-kB1 p105 and NF-kB2 p100 proteins share structural similarities. In addititon, GST-LYL1 proteins did not retain IkBa from cell lysates, in spite of its high homology with the C-terminus region of p105, particularly within the ankyrin-like domain.
The functional consequences of overexpression of LYL1 in the Jurkat T cell line was a decrease in kB element-dependent transcriptional activity. The molecular mechanisms responsible for this inhibition are unclear. Our data showed that the inhibition of the reporter gene expression was dependent on the level of expression of LYL1 products and exceeded 50% when transgene expression was driven by a strong promoter. These results suggested that LYL1 exerted a downmodulation of NF-kB-dependent transcriptional activity. This could be due to a diminution of available active Rel/NF-kB factors. Indeed, high ectopic expression of LYL1 caused a reproducible reduction of the amount of NF-kB1 proteins. Strinkingly, the ratio of p105 to p50 was strongly reduced in T cells expressing high levels of LYL1 products. This suggested a relative increase of p105 proteolysis associated to a p50 augmentation. The normal p105 processing is mediated by the ubiquitine-proteasome pathway and requires the phosphorylation of serines 894 and 908 (Fujimoto et al., 1995; MacKichan et al., 1996; Palombella et al., 1994) . Interestingly, we mapped the LYL1-interacting domain of p105 to its C-terminus, which are close to these phosphorylation Figure 8 High levels of LYL1 proteins correlate with reduced p105 protein expression in Jurkat T cells. Two independent Western blots were performed using 25 mg of whole cell lysates prepared from dierent Jurkat cell sublines and probed respectively with LYL1 antibody and p105/p50 antibody. To obtain a true loading control, both membranes were cut according to the MW markers (between 30 kD and 45 kD) and probed independently with a GAPDH antibody; no signi®cant variation in the loadings was observed between the two blots. Empty: Jurkat cell population transfected with the empty pRc-CMV vector. LYL 60, LYL 62, LYL 42, and LYL 57 are independent clones isolated from the Jurkat cell population transfected with pRc-CMV-LYL1 targets. LYL1 might thus interfere with p105 Cterminal phosphorylations. One possibility is that LYL-1 addressed more eciently the precursor to the proteasome complex, as reported for the HTLV1 transactivator Tax (Rousset et al., 1996) . Another possibility is that LYL1, since it appeared to be subjected to a proteolytic maturation (our observations, Figure 4 ), upon interaction with p105 diverts the latter protein from its normal processing pathway. In regard to p105 IkB-like function, the relative diminution of p105 in LYL1 transfectants is likely to result in an increase of free p50 subunits available to form homodimers. Such NF-kB dimers, devoid of a strong transcriptional domain, might act as putative transcriptional inhibitors (Kang et al., 1992) . Such a mechanism might also account in part for the signi®cant decrease of p105 since NF-kB is known to exert a positive autoregulation on its own NF-KB1 gene expression (Ten et al., 1992) . These dierent hypothesis are not necessary exclusive and require further experiments.
We observed that the inhibition of NF-kB activity resulting from LYL-1 ectopic expression in T cells never exceeded 60%, even when the transgene was driven by a strong promoter. Under the same conditions, IkBa had a much stronger inhibitory eect (unpublished results). This suggests that, compared to IkBa overexpression, which is expected to interfere with the whole NF-kB system, LYL1 overexpression aects only some elements of the NFkB system. This is in agreement with our ®ndings that LYL1 interacted with NF-kB1 p105 but not with other NF-kB/Rel members.
Several cases of T cell neoplasias have been associated with a dysfunction of the NF-kB system (for review, see Gilmore et al., 1996) . Aberrant NFkB2 proteins are found in human T cell lymphomas as a result of speci®c chromosome rearrangement (Chang et al., 1995; Migliazza et al., 1994) and transgenic mice expressing v-Rel in the T cell lineage develop aggressive T cell lymphomas (Carrasco et al., 1996) . From the results of our study, it could be speculated that ectopic expression of LYL1 in human leukemic T cells may also disturb NF-kB activity, thus aecting the expression of NF-kB downstream target genes. NFkB is likely to play a signi®cant role in the development and homeostatic control of T cells. A constitutive repressor of NF-kB, an IkBa protein insensitive to induced degradation, has recently been described to perturb T lymphocyte development (Boothby et al., 1997) . Several recent studies have also implicated NF-kB in the control of apoptosis (for review, Baichwal and Baeuerle, 1997) . Surprisingly, the various NF-kB/Rel factors appeared implicated as well in the promotion as in the inhibition of cell death, depending on the cell type, the nature of the apoptosisinducing stimulus and the simultaneous presence of additional factors (Beg and Baltimore, 1996; Grilli et al., 1996; Liu et al., 1996; Van Antwerp et al., 1996) . For example, overexpression of bcl 2, known to prevent apoptosis, reduces NF-kB-dependent transcriptional activity (Grimm et al., 1996) and apoptotic cell death was reported upon c-Rel overexpression (Abbadie et al., 1993) . Further studies have to be conducted to test the possibility that abnormal LYL1 expression may indirectly aect the control of apoptosis of immature T cells, as has already been demonstrated for TAL-1 (Condorelli et al., 1997; Leroy-Viard et al., 1995) .
Material and methods
Cell cultures and stable transfections
The Jurkat T cell line and K562 erythroid cell line were maintained in RPMI 1640 containing 10% decomplemented FCS. The pluripotent cell line UT7 was maintained in I-MEM containing 10% decomplemented serum in the presence of GM-CSF (2.5 ng/ml). Jurkat/empty, Jurkat-LYL and two derived sub-clones, LYL-60 and LYL-62 were established by transfecting parental Jurkat cells with the plasmid pRc-CMV (In Vitrogen) or pRc-CMV-LYL1, respectively, and selecting for resistance to G418 (1 mg/ml; Geneticin, GIBCO-BRL). All stable transfectants were thereafter maintained in the above medium supplemented with 0.5 mg/ml G418. All transfections were performed using DMRIE-C reagent (GIBCO-BRL) as per the manufacturer's instructions. LYL1 expression was con®rmed by Northern blot analysis using the LYL1 cDNA as a probe.
Plasmids
A 300 bp fragment of LYL1 cDNA ampli®ed by RT ± PCR according to the sequence described by Mellentin et al, (1989) was used to screen a cDNA library established from the human erythro-megakaryocytic cell line HEL. The cDNA LYL1 clone used in this study begins at nt 194 of the published sequence (Mellentin et al., 1989) , and thus contains the ®rst ATG of the ORF and encodes the full length LYL1 proteins. To construct the expression vectors, the LYL1 cDNA insert was subcloned into the pRc-CMV (In Vitrogen) or pcDL-SRa296 vector (Takebe et al., 1988) .
LYL1-LF (Long Form) designs a second cDNA clone which contains nucleotides 3 ± 1348, according to the numbering of Mellentin et al. (1989) and encompasses the potential CTG translation initiation codon (nt 127) in frame with the ®rst favorable ATG codon (nt 259). RT ± PCR was performed on total RNA from UT7 cells using the following primers:
Upper: 5'-AACTGCAGAGACCTCGGCTAT-CCTGG-3' Lower: 5'-AATGTAGACACTGTTGAGGAA-GGGGT-3' (thus including the unique Acc I site present in the LYL1 coding sequences), 100 mM dNTP's, 10% DMSO, Expand TM High Fidelity Polymerase (Boehringer) and buer supplied with. PCR conditions were an initial denaturation at 948C for 10 min prior to 25 cycles of 1 min denaturation at 948C, 1 min annealing at 558C and 1 min extension at 728C. PCR products were ligated to pGEMT Easy Vector (Promega) and sequenced. It was subcloned according the PstI and AccI sites into our previous LYL-1 cDNA clone deleted from its 5' terminus encompassing nucleotide 195 to AccI site, position 556 ± 561 (Mellentin et al., 1989) .
pBTM-LYL1 was constructed by inserting a LYL1 cDNA fragment from the endogenous AccI to the stop codon (encoding aa 114 ± 280 which includes the bHLH domain) fused to the DNA binding domain of LexA into the BamHI-PstI sites of pBTM116. pBTM-TAL-1 bHLH was generated by PCR and encodes residues 172 ± 289, including the bHLH domain. The full length LMO-2 cDNA, kindly provided by B Royer-Pokora (Heidelberg, Germany), was fused to the activating domain of GAL4 of pGAD 3S2X. The pGAD-IkBa plasmid was provided by Stern (INSERM U 462, Paris, France). All recombinant pGEX vectors were generated by PCR and cloned into the appropriate sites of either pGEX-2 or pGEX-3 plasmids (Pharmacia Biotech, Uppsala, Sweden). pGEX-LYL1bHLH contains aa 114 ± 221 of LYL-1; pGEX-LYL1 contains aa 16 ± 280 of LYL-1; pGEX-TAL-1bHLH contains aa 172 ± 289 of TAL-1; pGEX-TAL2 bHLH contains aa 1 ± 96 of TAL-2; pGEX-E12 bHLH encompasses aa 283 ± 397 of E12; pGEX-MYOD encompasses aa 96 ± 240 of MYOD.
All these clones were sequenced to verify their wild type genotype and maintenance of reading frame in the resulting fusion protein. The (Igk)3-conaluc and conaluc reporter plasmids, kindly provided by Israel (Institut Pasteur, Paris, France) have been previously described (Munoz et al., 1994) ; the (Igk)3-conaluc contains three copies of the immunoglobulin k chain enhancer kB site upstream of the minimal conalbumin promoter fused to the ®re¯y luciferase reporter gene.
Two-hybrid screening
Screening was performed in the L40 yeast strain (MATa trp1 leu2 his3 LYS2::lexA-His3 URA3::lexA-LacZ). Interactions were assayed by mating L40 strains expressing LexA fusions to AMR70 strains (MATa his3D200, lys2 ± 2 ± 801am, trp1 ± 901, leu2 ± 3, 112, ade2, URA3::lexA-lacZ) expressing Gal4 activating domain fusions. The original strain was grown in YPD medium (1% yeast extract, 2% bacto-peptone, 2% glucose) and recombinant clones in synthetic Drop Out (DO) minimal medium without tryptophan (W), leucine (L) and/or histidine (H) (DO-WLH) in accordance with the prototrophy carried by the recombinant vector.
Transformed L40 were grown on DO-W medium owing to the prototrophy carried by pBTM 116. The L40 strain was co-transformed with pBTM-LYL1 bHLH and an oligo(dT)-primed Jurkat cDNA library, kindly provided by J Camonis (Inserm U248, Paris, France). Double transformants (15610 6 ) were plated on DO-WLH and allowed to grow at 308C for 3 days. His+ colonies were patched on selective media, transferred onto Whatman 40 ®lters and assayed for b-galactosidase activity. pGAD vectors from positive clones were rescued in HB101 bacteria, and checked for speci®city against the LYL1 bHLH and Lamin. Speci®c clones were sequenced and analysed using the BLAST algorithm on EMBL and GenBank databases.
Pull-down assays
The dierent GST fusion proteins were prepared as described previously (Pulford et al., 1995) except that they were kept bound to glutathione-Sepharose beads (Pharmacia Biotech, Uppsala, Sweden) in order to perform in vitro binding assays. Bound beads (containing about 3 mg of protein) were incubated with 5 ± 10 ml of reticulocyte lysate for 1 h at 48C in NTEN buer (100 mM NaCl; 20 mM Tris-HCI, pH 8; 1 mM EDTA; 0.5% NP40). The beads were then washed four times with cold NTEN buer, and the bound proteins were separated by SDS ± PAGE and visualized by autoradiography.
GST precipitation of cellular proteins
After a brief wash with ice-cold phosphate buered saline (PBS), cells were lysed in EBC buer (50 mM Tris-HCl pH 8; 120 mM NaCl; 0.5% NP40; 100 mM NaF; 100 mM Na-orthovanadate; protease inhibitor cocktail, Boehringer Mannheim). After a 30 mn centrifugation at 12 000 r.p.m., lysates were precleared by incubation with GST bound to glutathione agarose beads for 2 h at +48C. Precleared extracts containing equal amounts of proteins (300 mg) were incubated in HNT buer (20 mM HEPES pH 7.4; 100 mM NaCl; 2 mM MgCl2; 0.1 mM EDTA; 0.5% NP40; 0.05% Triton X-100) with 5 mg of each GST fusion protein bound to glutathione-Sepharose beads with gentle rocking at +48C overnight. The beads were then washed four times in PBS and once with RIPA buer (25 mM Tris-HCl pH 7.5; 50 mM NaCl; 2 mM EDTA; 0.5% NP40; 0.5% Na deoxycholate). Bound proteins were separated by SDS ± PAGE and revealed by Western blot analysis as described above.
Coimmunoprecipitation
Cos 7 cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) plus 10% fetal calf serum (Biomed). Cells were plated in 90 mm diameter dishes and incubated at 378C until they were 30% con¯uent. Expression vectors empty pCS3 or pCS3-p105 (in which p105 coding sequences were fused in frame with the MYC tags) were transfected together with either pRC-CMV empty or pRC-LYL or pRC-LYL-LF according to the Lipofectamine reagent procedure (GIBCO-BRL). 0.5 mg of the pGL3-promoter Luc reporter plasmid (Promega) was also added to estimate transfection eciencies. Fortyeight hours after transfection, cells were lysed in Tris pH 7,5 20 mM, EDTA 1 mM, NaCl 140 mM, PMSF 1 mM, Na-orthovanadate 1 mM, protease inhibitor cocktail (Boehringer), 1% Brij 97 (polyoxyethylene 10 oleyl ether) for 40 min at 48C. Coimmunoprecipitations were performed using 200 mg whole cell lysate proteins. Each sample was incubated with 1 ml of rabbit anti-LYL1 antibody for 4 h at 48C, and then for 1 h with 20 ml of Protein A-Sepharose (Pharmacia). Pellets were washed three times with 1 ml of lysis buer, and immune complexes were eluted with Laemmli Loading Buer and loaded onto a 10% SDS ± PAGE gel. Proteins were blotted on PVDF membrane and probed with the monoclonal antibody 9E10 directed against the tag MYC. The LYL1 antibody, kindly provided by Drs Miyamoto and M Cleary (Stanford, USA) is a polyclonal rabbit serum directed against the carboxy-terminus (including the HLH domain) of LYL1 (Miyamoto et al., 1996) .
Immunoblot analysis (Western blot)
Whole cell lysates and immunoblots were performed as described previously . Extracts with equal amount of proteins were resolved on a 12% SDS ± polyacrylamide, transferred onto PVDF membranes (NEN, Boston, USA) and revealed with a rabbit polyclonal antibody either against p105/p50, kindly provided by A Israel (Inst. Pasteur, Paris, France) or against GAPDH (a gift of JM Blanchard, Montpellier, France). The primary antibody was detected with horseradish peroxydase-linked antibodies and visualized by the ECL detection kit (Amersham, UK).
Transient transfections and luciferase assay
The day prior to transfection, Jurkat cells were seeded at 10 6 /ml in fresh medium. 3610 6 cells were transfected using DMRIE-C reagent with either 2 mg of (Igk)3-conaluc plasmid or its control counterpart, conaluc. In a set of experiments, as indicated in the ®gures, cells were cotransfected with 1 mg pcDL-SRa296 expression vector. The TK-RL plasmid (Promega) encoding the Renilla luciferase reporter was cotransfected in each experiment to correct for transfection eciency. Forty hours post transfection, cells were incubated in the presence or absence of PMA for 6 h (except in the kinetics experiments) and analysed for luciferase activity using the Dual luciferase kit (Promega). Fire¯y luciferase activity in each sample was normalized with Renilla luciferase activity. All results were expressed as the ratio of NF-kB-mediated luciferase activity (i.e. due to (Igk)3-conaluc plasmid) to the Iuciferase activity due to the control counterpart plasmid (conaluc).
Statistical analysis
Mann and Whitney's tests were used to compare data assessing the relative eects of LYL1 or other proteins on the (Igk)3-Luc reporter activity. Each assay comprised at least ®ve repetitions, and experiments were performed in triplicate or more. Statistical risks of error are designated a in the text.
